Tenaya Therapeutics (TNYA) Non-Current Assets (2020 - 2026)

Tenaya Therapeutics' Non-Current Assets history runs 7 years deep, the most recent figure standing at $38.5 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 22.15% year-over-year to $38.5 million; the TTM figure through Mar 2026 stood at $169.9 million (down 21.16% YoY), while the FY2025 annual figure was $41.3 million, down 21.36% from the prior year.
• Non-Current Assets was $38.5 million for Q1 2026 at Tenaya Therapeutics, down from $41.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $90.7 million in Q1 2023 to a low of $38.5 million in Q1 2026.
• Historically, Non-Current Assets has averaged $60.7 million across 5 years, with a median of $58.2 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets soared 60.82% in 2022, then slumped 38.05% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $85.2 million in 2022, then plunged by 30.82% to $58.9 million in 2023, then slipped by 10.81% to $52.6 million in 2024, then decreased by 21.36% to $41.3 million in 2025, then dropped by 6.84% to $38.5 million in 2026.
• The last three Non-Current Assets figures came in at $38.5 million (Q1 2026), $41.3 million (Q4 2025), and $43.7 million (Q3 2025), per Business Quant data.